Sotevtamab

Tax included
Sotevtamab (16B5) is a humanized IgG2 anti-clusterin monoclonal antibody (mAb). Sotevtamab is an inhibitor of the epithelial to mesenchymal transition. Sotevtamab can be used for cancer research.
MedChemExpress 
HY-P99589

Data sheet

Size
Multiple sizes
Reactivity
Apoptosis
CAS
2411526-47-9